Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: Evaluation by multivariate regression analysis

Oncology

Volumn 57, Issue 2, 1999, Pages 106-114

  Hirose, Kazuo ^a   Katayama, Kanji ^a   Iida, Atsushi ^a   Yamaguchi, Akio ^a   Nakagawara, Gizo ^a   Umeda, Syun Ichi ^a   Kusaka, Yukinori ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Gastric cancer; Hyperthermic peritoneal perfusion; Multivariate regression analysis; Peritoneal metastases

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE METASTASIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; HYPERTHERMIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORGAN PERFUSION; PERITONEUM METASTASIS; PRIORITY JOURNAL; REGIONAL PERFUSION; REGRESSION ANALYSIS; STOMACH CANCER; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; ETOPOSIDE; FEMALE; HEAT; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; MULTIVARIATE ANALYSIS; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0032877211     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012016     Document Type: Article

References (30)

1. Baba H, Korenaga D, Okamura T, Saito A, Sugimachi K: Prognostic factors in gastric cancer with serosal invasion. Arch Surg 1989;124: 1061-1064.
2. Iitsuka Y, Kaneshima S, Tanida O, Takeuchi T, Koga S: Intra-peritoneal free cancer cells and their viability in gastric cancer. Cancer 1979; 44:1476-1480.
3. Koga S, Kaibara N, Iitsuka Y, Kudo H, Kimura A, Hiraoka H: Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol 1984; 108:236-238.
4. Torisu M, Katano M, Kimura Y, Ito H, Takesue M: New approach to management of malignant ascites with a streptococcal preparation, OK-432: Improvement of host immunity and prolongation of survival. Surgery 1983;93:357-364.
5. Hiratsuka M, Furukawa H, Iwanaga T, Nakamori S, Kameyama M, Sasaki Y, Kabuto T, Ishikawa O, Koyama H, Imaoka S: Adjuvant intraperitoneal high-dose chemotherapy with mitomycin C in patients with primary advanced gastric cancer; in Takahashi T (ed): Recent Advances in Management of Digestive Cancers. Tokyo, Springer, 1993, pp 422-424.
6. Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Ito T: Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C absorbed on activated carbon particles. Cancer 1987;59:43-49.
7. Yamada T, Ohira M, Hikishima H, Hashizume Y, Yamashita R, Kawaura Y: Intraabdominal administration of CDDP for management of carcinomatous peritonitis (in Japanese with English abstract). Jpn J Cancer Chemother 1986;13:1004-1009.
8. Honda I, Watanabe S, Fujita Y, Watanabe K, Ryu M, Kawakami Y: Intermittent administration of CDDP(CBDCA), VP-16 for serosal exposing stomach carcinoma (in Japanese with English abstract). J Jpn Soc Clin Surg 1992;53: 1790-1797.
9. Shiu MH, Fortner JG: Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats. Cancer Res 1980;40:4081-4084.
10. Spratt JS, Adcock RA, Muscovin M, Sherrill W, McKeown J: Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:256-260.
11. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T: Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232-237.
12. Fujimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T, Sugiyama K, Hasegawa H, Katayama K, Miwa K, Miyazaki I: Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65-71.
13. Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura K, Sawa T, Katayama K, Tanaka S, Hirono Y, Miwa K, Miyazaki I: Prophylaxis with intraperitoneal chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995; 19:450-455.
14. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Arimizu N, Takamizawa H: Intraperitoneal hyperthermic peritoneal perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36-41.
15. Hamazoe R, Maeta M, Kaibara N: Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994;73:2048-2052.
16. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I: Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530-536.
17. UICC International Union Against Cancer. TNM classification of malignant tumors, ed 4, fully rev ed. Berlin, Springer, 1987.
18. Japanese Research Society of Gastric Cancer: Japanese Classification of Gastric Carcinoma, 1st Engl ed. Tokyo, Kanehara, 1995, pp 1-17.
19. Howell SB, Pfeifle CE, Wung WE, Olshen RA: Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 1983;43:1426-1431.
20. Zim S, Clear SM, Lucas WE, Weiss RJ, Markmann M, Andrews PA, Shiefer MA, Kim S, Horton C, Howell SB: Phase I/pharmacokinetics study of intraperitoneal cisplatin and etoposide. Cancer Res 1987;47:1712-1716.
21. Katayama K, Note M, Fujita H, Nakagawara G: Continuous hyperthermic peritoneal perfusion using peritoneal cavity expander; in Sugahara T, Saito M (ed): Hyperthermic Oncology 1988. London, Taylor & Francis, 1989, vol I, pp 450-451.
22. Leroy AF, Wehling ML, Sponseller HL, Freauf WS, Solomon RE, Dedrick RL: Analysis of platinum in biological materials by flameless atomic absorption spectrophotometer. Biochem Med 1977;18:184-186.
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
24. Cox DR: Regression models and life tables. J R Stat Soc B 1972;34:187-220.
25. Sugarbaker PH: Intraperitoneal chemotherapy and cytoreductive surgery. Grand Rapids, Ludann Company, 1995, pp 1-20.
26. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, Steves MA, Sugarbaker PH: Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996;77:2622-2629.
27. Nagayo T: Histogenesis and Precursors of Human Gastric Cancer. Berlin, Springer, 1986, pp 17-39.
28. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T, Isawa E, Sumida M, Ohkubo H: Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997;79:884-891.
29. Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-132.
30. Yonemura Y: Contemporary approaches toward cure of gastric cancer. Kanazawa, Maeda Shoten, 1996, pp 163-176.